World AIDS Day

India’s HIV Prevalence Declined to 0.20% in 2024: Achievements, Gaps, and Challenges

On December 1, 2025 — World AIDS Day — India reached a milestone worth reflecting upon. HIV prevalence in the country has declined from 0.33% in 2010 to 0.20% in 2024, marking a significant drop compared to the global average of 0.7%. Yet, while these statistics signal success, the theme for this year — Overcoming Disruption, Transforming the AIDS Response — highlights hurdles that still plague India’s HIV/AIDS efforts. The emergence of pandemics, deepening inequalities, and healthcare disruptions demand critical scrutiny. Numbers alone don’t tell the full story.

Why This Decline Challenges Global Trends

India’s achievements are notable for defying several global patterns. First, it accounts for only 5% of the world’s new infections, despite having 17% of the global population — a stark outlier for a developing country. Second, the country’s HIV prevalence has declined more sharply compared to many Sub-Saharan African nations where rates remain stubbornly high. In South Africa, for instance, adult prevalence still hovers around 19.6% as of 2024, highlighting an ongoing epidemic. While India’s decentralized strategies, supported by the National AIDS Control Programme (NACP), have helped curb infections by ramping up testing and broadening antiretroviral therapy (ART) access, South Africa's persistent struggle underscores critical differences in institutional capacity and funding mechanisms.

However, even within India’s lower prevalence rates, gaps exist. Regional inequities show concentrated HIV burdens in northeastern states like Mizoram, where prevalence reportedly exceeds 1%, compared to states like Kerala at sub-0.1% levels. Such disparities demand local solutions — policies attuned to state-specific vulnerabilities, health infrastructures, and socioeconomic barriers.

The Institutional Backbone: National AIDS Control Programme

India's HIV/AIDS response is anchored in the National AIDS Control Programme (NACP), now in its fifth phase (2021–2026). What sets the NACP apart is its evolution over time: from awareness campaigns under NACP I to ambitious goals like halting the epidemic under NACP III (2007–2012). NACP IV shifted focus to sustainability, culminating in initiatives like Mission Sampark to retrieve dropout patients, and universal viral load monitoring introduced during its extension (2017–2021).

The programme operates under the HIV/AIDS (Prevention and Control) Act, 2017, a landmark legislation prohibiting discrimination against people living with HIV (PLHIV). Section 14 of the Act guarantees that PLHIVs cannot be denied healthcare access due to their status—a legal mechanism necessary yet rarely enforced beyond major urban centers. Importantly, NACP V aligns with UN Sustainable Development Goal 3.3: ending AIDS as a public health threat by 2030.

The financial matrix, however, reveals constraints. Funding allocations for NACP V remain modest compared to the size of the challenge. India spent approximately ₹2,000 crore annually on HIV/AIDS during 2023-2024, reflecting a drop compared to peak investment levels in NACP III. Reliance on external partnerships like those with UNAIDS and the Gates Foundation mitigates financial pressures but reflects an ongoing dependence on international backing — a vulnerability in periods of geopolitical instability.

Beyond Official Claims: Data and Disruption

Despite progress at the macro level, challenges linger beneath stated achievements. The government’s claim that antiretroviral therapy covers 80% of the eligible population, for instance, obscures the reality of treatment gaps for hard-to-reach groups. High-Risk Groups (HRGs), including sex workers and injecting drug users, remain difficult to engage comprehensively, especially post-pandemic disruptions. Case in point: When examining routine ART adherence, data from the NACO Progress Report 2023 revealed dropout rates nearing 12%, highlighting flaws in retention mechanisms.

Community-driven stigma also persists, dragging down testing rates despite expanded campaigns. Reports indicate that fear of discrimination causes delays in diagnosis, with 43% of HIV cases identified only in late stages. Public communication strategies have struggled to dismantle entrenched prejudices, as educational material often fails to adapt to cultural and linguistic diversity within the country.

Uncomfortable Questions: Funding, Fragmentation, and Equity

The 2025 theme — Overcoming Disruption — demands uncomfortable questions about India's preparedness for emerging challenges. First, has scaling down budget allocations under NACP V compromised resilience against global pandemics? The experience during COVID-19 laid bare vulnerabilities in ART supply chains, with northeastern states particularly affected due to reliance on logistical hubs in Delhi and Mumbai.

Second, is the programme over-centralized? While NACO operates as the apex institution, its coordination mechanisms with state AIDS Control Societies remain fragmented in regions with weaker governance capacities. Urban-rural divides further exacerbate disparities, as rural populations struggle with inadequate testing infrastructure despite higher HIV vulnerabilities.

Lastly, what role does private healthcare play? While the Act mandates non-discriminatory services in private hospitals, enforcement mechanisms are far from robust. Corruption within public-private partnerships related to ART distribution merits closer scrutiny, as several audits have raised concerns over inflated procurement costs.

Learning from the South Korean AIDS Model

South Korea’s HIV/AIDS response offers an illuminating contrast. With sub-0.05% prevalence, Korea has shown that active integration of PLHIV into mainstream welfare policies — such as housing support and employment protections — can significantly lower stigma-related barriers. India's focus is disproportionately biomedical: ART, testing kits, and outreach models targeting High-Risk Groups dominate the current programme. South Korea, on the other hand, integrates HIV policy within broader social protections — a structural shift that India could emulate for enduring impact beyond 2030.

Prelims Practice Questions

Practice Questions for UPSC

Prelims Practice Questions

Frequently Asked Questions